QR Code

Ocrelizumab in treatment of primary-progressive multiple sclerosis: systematic review

Aim. To analyze the efficacy, safety and pharmacoeconomic indicators of ocrelizumab in adult patients with primary progressive multiple sclerosis (PPMS). Methods. An information search was conducted in the databases Embase, PubMed, Cochrane and eLibrary.ru. The levels of evidence were determined in...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: D. L. Klabukova, M. E. Holownia-Voloskova, M. V. Davydovskaya, T. N. Ermolaeva, E. M. Olyushina, K. I. Polyakova, A. G. Fisun, M. G. Grinin, K. A. Kokushkin
Hōputu: Artigo
Reo:Russo
I whakaputaina: Izdatelstvo OKI 2018-07-01
Rangatū:Качественная клиническая практика
Ngā marau:
окрелизумаб
эффективность
безопасность
систематический обзор
первично-прогрессирующий рассеянный склероз
анти-в-клеточная терапия
моноклональные антитела
Urunga tuihono:https://www.clinvest.ru/jour/article/view/405
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite